# Ganoderma lucidum 'Green Reishi'

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ganoderma-lucidum-green-reishi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-30
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Ganoderma lucidum cultivar Green, Green Lingzhi, Green Reishi mushroom, Ganoderma lucidum var. Green, Green cultivar reishi, Lingzhi Green variety

## Overview

Ganoderma lucidum 'Green Reishi' is a cultivated variant of reishi mushroom that produces polysaccharides — including exopolysaccharides (EPS) up to 2.49 g/L and intracellular polysaccharides (IPS) up to 4.8 g/L — which are its primary bioactive compounds of interest. Current evidence is limited to in vitro studies demonstrating antibacterial activity, with no human clinical trials conducted to date.

## Health Benefits

• No human clinical evidence available - only in vitro antibacterial activity reported
• Traditional use in Asian medicine systems documented but without specific health claims verified
• Cultivation produces polysaccharides (EPS up to 2.49 g/L, IPS up to 4.8 g/L) - compounds of interest but no proven benefits
• Contains ganoderic acids (up to 582 mg/L in fermentation) - bioactive compounds without established clinical effects
• Evidence quality: No human trials found in research dossier

## Mechanism of Action

Green Reishi's polysaccharides, particularly [beta-glucan](/ingredients/condition/immune-support)s within the EPS and IPS fractions, are hypothesized to interact with pattern recognition receptors such as Dectin-1 and TLR-2 on immune cells, potentially stimulating macrophage activation and [cytokine](/ingredients/condition/inflammation) release. In vitro antibacterial activity may involve disruption of bacterial cell membrane integrity, though the precise molecular targets remain uncharacterized. Triterpene compounds common to Ganoderma species, such as ganoderic acids, may also inhibit enzymes like HMG-CoA reductase and NF-κB signaling pathways, though these have not been specifically confirmed for the Green Reishi variant.

## Clinical Summary

No human clinical trials have been conducted specifically on Ganoderma lucidum 'Green Reishi,' making it impossible to confirm efficacy or optimal dosing in people. Available evidence is restricted to in vitro laboratory studies reporting antibacterial activity and polysaccharide quantification during cultivation optimization. Traditional use in Asian medicine systems — including Chinese and Japanese herbal traditions — provides historical context but does not constitute verified clinical evidence under modern standards. The polysaccharide yields (EPS up to 2.49 g/L; IPS up to 4.8 g/L) are well-characterized in fermentation research, but whether these concentrations translate to therapeutic benefit in humans is entirely unknown.

## Nutritional Profile

Ganoderma lucidum 'Green Reishi' shares the general nutritional framework of Ganoderma species with some strain-specific variations. Macronutrients (per 100g dry weight, approximate): Protein 10–18g (containing all essential amino acids, notably glutamic acid, aspartic acid, and leucine as dominant fractions); Carbohydrates 55–75g (predominantly structural polysaccharides and fiber); Dietary fiber 50–65g (high insoluble beta-glucan content); Fat 1–3g (predominantly unsaturated fatty acids including oleic and linoleic acid); Moisture in fresh fruiting body 85–92%. Key bioactive compounds: Beta-glucan polysaccharides — exopolysaccharides (EPS) documented at up to 2.49 g/L in liquid fermentation culture; intracellular polysaccharides (IPS) up to 4.8 g/L — these are (1→3)-beta-D-glucan and (1→6)-beta-D-glucan backbone structures with [immunomodulatory](/ingredients/condition/immune-support) interest but unconfirmed clinical efficacy; Ganoderic acids (triterpene family) — quantified at up to 582 mg/L in fermentation conditions, including ganoderic acids A, B, C, D, G, and H; bioavailability is limited by poor aqueous solubility and first-pass [metabolism](/ingredients/condition/weight-management), enhanced by ethanol or hot-water extraction; Ergosterol (provitamin D2 precursor) 0.3–1.5 mg/g dry weight — converts to vitamin D2 upon UV exposure, though conversion in finished product depends heavily on processing; Minerals: potassium (dominant, ~1,800–3,500 mg/100g dry), phosphorus (~500–900 mg/100g dry), magnesium (~80–200 mg/100g dry), calcium (~20–80 mg/100g dry), zinc (~5–15 mg/100g dry), iron (~4–12 mg/100g dry), selenium trace amounts (~0.01–0.1 mg/100g dry, highly substrate-dependent); B-vitamins: riboflavin (B2) ~0.4–1.2 mg/100g dry, niacin (B3) ~5–10 mg/100g dry, pantothenic acid (B5) ~1–3 mg/100g dry; Adenosine and nucleosides present in small quantities (~0.1–0.5 mg/g dry); Lectins reported in fruiting body at low concentrations. Bioavailability notes: Raw fruiting body polysaccharides have low bioavailability due to chitin cell wall encapsulation — hot-water extraction or dual extraction (water + ethanol) significantly increases bioactive yield; ganoderic acids require alcohol-based extraction for meaningful recovery; the 'Green Reishi' color variant is associated with specific cultivation conditions (often cooler temperatures or particular substrate formulations) but nutritional differentiation from red Ganoderma lucidum strains is not robustly characterized in peer-reviewed literature — compositional differences are presumed minor but strain-validated data is limited.

## Dosage & Preparation

No clinically studied dosage ranges are available for Ganoderma lucidum 'Green Reishi' as human trials are absent from the research. Double-extraction methods (water boiling 2-3 hours followed by dehydration) are used for processing, but consumption dosing remains unstudied. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Because no human trials exist for Green Reishi specifically, a complete safety profile has not been established, and side effects cannot be quantified with confidence. General Ganoderma lucidum preparations have been associated with mild adverse effects including digestive upset, dry mouth, and skin rash, and rare cases of hepatotoxicity have been reported with prolonged use of powdered whole mushroom products. Potential drug interactions include additive effects with anticoagulants such as warfarin — due to possible platelet aggregation inhibition by triterpenes — and theoretical interactions with immunosuppressants given the [immunomodulatory](/ingredients/condition/immune-support) properties of beta-glucans. Pregnant or breastfeeding individuals and those with autoimmune conditions or scheduled surgeries should avoid use until safety data specific to this variant are available.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were found for Ganoderma lucidum 'Green Reishi' in the research dossier. The only study mentioned evaluated antibacterial activity using in vitro methods but lacked human data, sample sizes, or PubMed citations. Clinical evidence for this cultivar variant is currently absent.

## Historical & Cultural Context

Ganoderma lucidum has been used in traditional Asian medicine systems, particularly in Chinese medicine where it is known as 'Lingzhi.' However, the research focuses on modern cultivation methods rather than historical applications or traditional indications for this specific 'Green Reishi' cultivar.

## Synergistic Combinations

Other Reishi variants, Turkey Tail, Cordyceps, Lion's Mane, Vitamin D3

## Frequently Asked Questions

### What is Green Reishi mushroom and how is it different from regular Reishi?

Green Reishi is a cultivated variant of Ganoderma lucidum distinguished by its green-tinged fruiting body coloration and specific cultivation characteristics. Like standard Reishi, it produces bioactive polysaccharides (EPS and IPS) and likely triterpenes such as ganoderic acids, but no comparative human studies exist to confirm whether its bioactive profile or potency differs meaningfully from other Ganoderma lucidum strains.

### Does Green Reishi have any proven health benefits?

Currently, Green Reishi has no proven health benefits supported by human clinical trials. Evidence is limited to in vitro (cell culture) studies demonstrating antibacterial activity and fermentation research confirming polysaccharide production — specifically EPS up to 2.49 g/L and IPS up to 4.8 g/L — neither of which constitutes proof of benefit in living humans.

### What are the main bioactive compounds in Green Reishi mushroom?

The primary bioactive compounds of interest in Green Reishi are its polysaccharides, including beta-glucan-rich exopolysaccharides (EPS) and intracellular polysaccharides (IPS), which are the most studied fractions in cultivation research. As a Ganoderma lucidum variant, it likely also contains triterpenes such as ganoderic acids A, B, and C, though these have not been specifically quantified or studied in this particular cultivar.

### Is Green Reishi mushroom safe to take as a supplement?

A definitive safety profile for Green Reishi specifically does not exist due to the absence of human trials. Extrapolating from general Ganoderma lucidum research, risks may include mild gastrointestinal discomfort, potential anticoagulant interactions (relevant to warfarin or aspirin users), and rare hepatotoxic effects associated with prolonged or high-dose use. Anyone with liver disease, autoimmune disorders, clotting conditions, or who is pregnant should consult a physician before use.

### What does in vitro antibacterial activity mean for Green Reishi supplements?

In vitro antibacterial activity means that Green Reishi extracts inhibited bacterial growth in a laboratory dish or cell culture setting — it does not mean the same effect occurs in the human body. Factors such as digestion, absorption, bioavailability, and systemic distribution can drastically alter whether an in vitro result translates to a real-world benefit, and without human trials, no antibacterial health claims for Green Reishi supplements are scientifically supported.

### How is Green Reishi cultivated, and does cultivation method affect polysaccharide content?

Green Reishi is typically cultivated through fermentation or solid-state culture methods that optimize polysaccharide production, with extracellular polysaccharides (EPS) reaching up to 2.49 g/L and intracellular polysaccharides (IPS) up to 4.8 g/L depending on growing conditions. The fermentation process also concentrates ganoderic acids to levels around 582 mg/L, which are considered bioactive compounds of research interest. Different cultivation techniques can significantly influence the final concentration of these compounds in the finished supplement. However, higher polysaccharide content does not necessarily translate to proven health benefits in humans.

### What is the difference between Green Reishi extract and whole fruiting body supplements?

Green Reishi extracts are typically concentrated products derived from fermentation or cultivation processes that isolate polysaccharides and ganoderic acids, while whole fruiting body supplements contain the complete mushroom material with varying compound concentrations. Extracts standardized to specific polysaccharide or ganoderic acid levels offer consistency, but no human clinical evidence currently demonstrates that one form is superior to the other in terms of effectiveness. Whole fruiting body forms may contain additional compounds not present in standardized extracts, though the bioavailability and efficacy of these additional compounds remain unverified in human studies.

### Does Green Reishi interact with medications that affect the immune system?

While Green Reishi contains bioactive compounds like polysaccharides and ganoderic acids that may theoretically influence immune function, there are no documented drug interaction studies or clinical evidence showing how Green Reishi supplements interact with immune-modulating medications. Individuals taking immunosuppressants, corticosteroids, or other immune-regulating medications should consult a healthcare provider before adding Green Reishi, as the lack of human clinical data makes it impossible to rule out potential interactions. The absence of reported interactions does not indicate safety, but rather reflects the limited clinical research available for this cultivar variant.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*